Kiora Pharmaceuticals Inc. (KPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2006 | |
| Operating Expenses | 6,678 | 2,462 | 3,098 | 5,852 | 0 |
| Operating Income | -6,678 | -2,462 | -3,098 | -5,852 | N/A |
| Interest Expense | 1,935 | 442 | 611 | 0 | 0 |
| Other Income | 224 | 1,352 | 27 | 44 | 0 |
| Pre-tax Income | -8,388 | -1,552 | -3,683 | -5,808 | 0 |
| Net Income Continuous | -8,388 | -1,552 | -3,683 | -5,808 | N/A |
| Minority Interests | 5 | 223 | 197 | 226 | N/A |
| Net Income | $-8,393 | $-1,774 | $-3,879 | $-6,034 | $N/A |
| EPS Basic Total Ops | -14,574.17 | -49,660.14 | -113,516.60 | -178,506.60 | N/A |
| EPS Basic Continuous Ops | -7,345.38 | -43,392.71 | -108,032.70 | -171,843.50 | N/A |
| EPS Diluted Total Ops | -14,574.17 | -49,660.14 | -113,516.60 | -178,506.60 | N/A |
| EPS Diluted Continuous Ops | -7,345.38 | -43,392.71 | -108,032.70 | -171,843.50 | N/A |
| EBITDA(a) | $-6,676 | $-2,460 | $-3,093 | $-5,843 | $N/A |